TGFB1 and Alzheimer disease: Compared to healthy aged individuals, reduced levels of TGF-β1 [including active (25 kDa) as well as inactive (50 kDa) forms] were observed in plasma and serum of AD patients along with the decline in TGF-β1 released from peripheral blood cells in circulation [68, 69].